Harneet Arora
0000-0002-6351-3941
Publication & Citation Trends
Publications
0 total
Time to third-line treatment after bendamustine-rituximab with or without acalabrutinib in patients with previously untreated mantle cell lymphoma: Updated analysis of the phase 3 ECHO trial after 50 months of follow-up
Cited by 2
Semantic Scholar
Immunological Disorders and Cancer Immunotherapy
Cited by 0
Semantic Scholar
Post-contractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy. OA
Cited by 3
Semantic Scholar
Modeling disease trajectory in Duchenne muscular dystrophy OA
Cited by 59
Semantic Scholar
Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort. OA
Cited by 35
Semantic Scholar
MR biomarkers predict clinical function in Duchenne muscular dystrophy OA
Cited by 71
Semantic Scholar
Duchenne muscular dystrophy: Still an incurable disease
Cited by 12
Semantic Scholar
Review of basic Concepts involved in Magnetic Resonance Imaging OA
Cited by 1
Semantic Scholar
DUCHENNE MUSCULAR DYSTROPHY – IMAGING AND BIOMARKERS
Cited by 0
Semantic Scholar
Measures to Prevent Overuse Injuries in Triathlon Athletes
Cited by 0
Semantic Scholar
Research Topics
Muscle Physiology and Disorders
(11)
Muscle activation and electromyography studies
(5)
Cardiomyopathy and Myosin Studies
(3)
Children's Physical and Motor Development
(3)
Musculoskeletal pain and rehabilitation
(2)
Affiliations
Children's Hospital of Philadelphia
University of Sfax
Guru Nanak Dev University
Oregon Health & Science University
Shriners Hospitals for Children - Portland